198 related articles for article (PubMed ID: 31181149)
21. The Association Between APOA5 Gene Polymorphisms and Plasma Lipids in the Turkish Cypriot Population: A Possible Biomarker for Preventing Cardiovascular Diseases.
Fahrioğlu U; Ergören MÇ
Biochem Genet; 2018 Jun; 56(3):176-187. PubMed ID: 29264753
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
23. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
[TBL] [Abstract][Full Text] [Related]
24. Quantitative trait loci at the 11q23.3 chromosomal region related to dyslipidemia in the population of Andhra Pradesh, India.
Pranavchand R; Reddy BM
Lipids Health Dis; 2017 Jun; 16(1):116. PubMed ID: 28610615
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study.
Zhu Y; Zhang D; Zhou D; Li Z; Li Z; Fang L; Yang M; Shan Z; Li H; Chen J; Zhou X; Ye W; Yu S; Li H; Cai L; Liu C; Zhang J; Wang L; Lai Y; Ruan L; Sun Z; Zhang S; Wang H; Liu Y; Xu Y; Ling J; Xu C; Zhang Y; Lv D; Yuan Z; Zhang J; Zhang Y; Shi Y; Lai M
J Cell Mol Med; 2017 Jun; 21(6):1106-1116. PubMed ID: 28371326
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein A5 gene variants are associated with decreased adiponectin levels and increased arterial stiffness in subjects with low high-density lipoprotein-cholesterol levels.
Kim M; Kim M; Yoo HJ; Bang YJ; Lee SH; Lee JH
Clin Genet; 2018 Nov; 94(5):438-444. PubMed ID: 30132804
[TBL] [Abstract][Full Text] [Related]
27. The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.
Bertoccini L; Sentinelli F; Incani M; Bailetti D; Cimini FA; Barchetta I; Cavallo MG; Cossu E; Lenzi A; Loche S; Baroni MG
Lipids Health Dis; 2017 Sep; 16(1):179. PubMed ID: 28927406
[TBL] [Abstract][Full Text] [Related]
28. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
Talmud PJ; Hawe E; Martin S; Olivier M; Miller GJ; Rubin EM; Pennacchio LA; Humphries SE
Hum Mol Genet; 2002 Nov; 11(24):3039-46. PubMed ID: 12417525
[TBL] [Abstract][Full Text] [Related]
29. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
30. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
31. The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides.
Dallongeville J; Cottel D; Wagner A; Ducimetière P; Ruidavets JB; Arveiler D; Bingham A; Ferrières J; Amouyel P; Meirhaeghe A
BMC Med Genet; 2008 Sep; 9():84. PubMed ID: 18789138
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia.
Hu M; Mak VW; Tomlinson B
J Clin Lipidol; 2012; 6(6):585-92. PubMed ID: 23312054
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal interaction between APOA5 -1131T>C and overweight in the acceleration of age-related increase in arterial stiffness through the regulation of circulating triglycerides.
Kim M; Yoo HJ; Lee HJ; Lee JH
Hypertens Res; 2019 Feb; 42(2):241-248. PubMed ID: 30451986
[TBL] [Abstract][Full Text] [Related]
34. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.
Laurila PP; Naukkarinen J; Kristiansson K; Ripatti S; Kauttu T; Silander K; Salomaa V; Perola M; Karhunen PJ; Barter PJ; Ehnholm C; Peltonen L
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):346-52. PubMed ID: 19910639
[TBL] [Abstract][Full Text] [Related]
35. Admixture mapping in two Mexican samples identifies significant associations of locus ancestry with triglyceride levels in the BUD13/ZNF259/APOA5 region and fine mapping points to rs964184 as the main driver of the association signal.
Parra EJ; Mazurek A; Gignoux CR; Sockell A; Agostino M; Morris AP; Petty LE; Hanis CL; Cox NJ; Valladares-Salgado A; Below JE; Cruz M
PLoS One; 2017; 12(2):e0172880. PubMed ID: 28245265
[TBL] [Abstract][Full Text] [Related]
36. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
[TBL] [Abstract][Full Text] [Related]
37. The "T" allele of apolipoprotein A5 rs2075291 is significantly associated with higher total cholesterol and triglyceride and lower high-density lipoprotein cholesterol levels in Asians: a meta-analysis.
Qian X; Li Y; Liu X; Li L; Yang K; Liu R; Zhang H; Shi Y; Yu F; Mao Z; Bie R; Wang C
Nutr Res; 2018 Aug; 56():11-22. PubMed ID: 30055770
[TBL] [Abstract][Full Text] [Related]
38. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
Arnedo M; Taffé P; Sahli R; Furrer H; Hirschel B; Elzi L; Weber R; Vernazza P; Bernasconi E; Darioli R; Bergmann S; Beckmann JS; Telenti A; Tarr PE;
Pharmacogenet Genomics; 2007 Sep; 17(9):755-64. PubMed ID: 17700364
[TBL] [Abstract][Full Text] [Related]
39. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
[TBL] [Abstract][Full Text] [Related]
40. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
